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1. Introduction
The design and development of reproducible, environmentally
benign and economical synthetic routes to drugs is of para-
mount importance in the pharmaceutical industry, and, in this
context, continuous-flow synthesis is receiving increasing at-
tention.[1–3] As a result, in recent years, many new flow-based
routes have been designed towards commercially available
active pharmaceutical ingredients.[4, 5]
We herein report an efficient chemoenzymatic flow synthesis
of captopril [(S)-1-[(S)-3-mercapto-2-methylpropanoyl]pyrroli-
dine-2-carboxylic acid, 5, Scheme 1]. Captopril is an angioten-
sin-converting enzyme (ACE) inhibitor and was discovered and
developed at E. R. Squibb & Sons Pharmaceuticals in the 1970s,
and is still a widely prescribed drug for the treatment of hyper-
tension.
Our flow-based synthetic route to obtain captopril includes
a first biocatalyzed heterogeneous regio- and stereoselective
oxidation reaction starting from a cheap prochiral diol (2-
methyl-1,3-propandiol, 1)[6, 7] followed, after isolation of carbox-
ylic acid 2, by three sequential chemical steps. The biocat-
alyzed flow oxidation offers an efficient alternative for environ-
mentally benign oxidations in answer to the critical economic
and environmental issues that urgently demand greener, more
atom-efficient and scalable oxidation methods.[8, 9] The oxida-
tion was performed using Acetobacter aceti MIM 2000/28;[10–12]
this strain is able to completely convert the substrate into (R)-
3-hydroxy-2-methylpropanoic acid (2) with an excellent ee (96–
97%) using a conventional batch-mode biotransformation. To
exploit all the advantages of performing (bio)catalyzed reac-
tions in flow, in particular the high local concentration of the
biocatalyst,[13–16] A. aceti has been immobilized as dried algi-
nate-entrapped cells, that are economical, easy to prepare and
can be efficiently used in a packed bed column.[17] Also, impor-
tantly, the use of whole cells in biocatalytic oxidation has the
great advantage of not requiring an additional cofactor regen-
eration system.
The following three chemical steps that yield captopril
under continuous flow conditions are depicted in Scheme 1. To
achieve this continuous-flow synthesis, the reactions have
been designed so that the excess of reagents and reaction by-
products from each reaction were compatible with the down-
stream reactions, in order to perform steps in sequence with-
out breaks in the workflow and manipulation. The risks associ-
ated with exothermic reactions and quenches (i.e. , the use and
neutralization of thionyl chloride) were mitigated owing to
two of the advantages of continuous flow over batch synthe-
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Scheme 1. Four-step chemoenzymatic synthesis of enantiomerically pure
captopril.
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sis : 1) only a small amount of material relative to the overall
output of the system is utilized at any given time, and 2) the
large surface-area-to-volume ratios that allow precise reaction
control through rapid heat transfer and mixing. Moreover, in-
line liquid–liquid extractions safely neutralized and removed
problematic reagents and by-products.
2. Results and Discussion
First, commercially available diol 1 (1 gL@1 in 20 mm acetate
buffer, pH 6) was successfully oxidized with dried alginate
beads of Acetobacter aceti MIM 2000/28 with high enantio-
and regioselectivity. The immobilized cells were prepared ac-
cording to a protocol recently reported by us,[17] packed into
a glass column (inner diameter 15 mm) and swelled by flowing
buffer through the column until their volume tripled. No re-
lease of catalyst in the exiting flow stream was observed. The
oxygen supply, essential for cofactor recycling, was ensured by
means of a segmented air–liquid flow stream (for details, see
the Experimental Section) formed before contact with the im-
mobilized biocatalyst (Scheme 2).
The reaction reached 95% conversion in only 10 min with
an excellent ee (96–97%), as determined by chiral gas chroma-
tography. The stability of the biocatalyst under continuous
work was assessed by performing the biotransformation under
the conditions reported in the Experimental Section. Using
400 mg of immobilized biocatalyst, a total volume of approxi-
mately 50 mL was collected. Samples collected at different
times were analyzed by HPLC and the results obtained in
terms of conversion were comparable over time, indicating
good stability under continuous work conditions. The maxi-
mum conversion (&95%) was observed for the first 35 mL of
collected solution. Then, the conversion slowly decreased to
80% in the following fractions. Therefore, the use of dried algi-
nate beads in flow offers good stability over the time, giving
95% conversion for approximately 10 h of continuous work.
However, the buffer flow stream, even if characterized by low
ionic strength (20 mm), might interfere with the alginate bead
structure, which could slowly release the biocatalyst and con-
sequently decrease the conversion.
Attempts to perform in-line acidification and extraction with
an organic solvent (e.g. , EtOAc) using a liquid–liquid separator
were not successful due to the high hydrophilicity of the ob-
tained carboxylic acid 2. Consequently, we exploited a catch-
and-release strategy using a column packed with Ambersep
900OH resin that trapped the acid, leaving unreacted starting
material in the exiting flow stream. Compound 2 was then re-
leased from the resin by using 1n HCl and lyophilized.
Then, starting from the isolated compound 2, we studied
the chlorination reaction with thionyl chloride with heating in
a pressurized system to effect both the formation of the acid
chloride and the direct chlorination of the primary alcohol
(Scheme 3). A 200 psi backpressure regulator (BPR) was used
to prevent outgassing. The possibility of conducting such an
exothermic reaction under heating conditions demonstrates
one of the operational advantages and capabilities of continu-
ous flow synthesis over analogous batch processes that require
cooling during the addition of thionyl chloride.
The reaction was tested in anhydrous toluene, THF, and
CH2Cl2 ; the reaction proceeded similarly with all the selected
solvents. Therefore, toluene was selected and a 1m solution of
compound 2 was used. An excess of thionyl chloride (3 equiv,
3m solution in toluene) was necessary to drive the reaction to
completion. A catalytic amount of imidazole and 10% DMF
(v/v) were added to the solution of 2. The use of DMF has
a double effect : first, it favored the reaction due to the forma-
tion of the Vilsmeier reagent and, second, it increased the solu-
bility of the starting material in toluene. Different reaction con-
ditions were then tested and they are summarized in Table 1.
The outcome was monitored by 1H NMR spectroscopy after
evaporation of the solvent. If no complete conversion was ob-
served, the starting material 2 and/or the acid chloride (with-
out substitution of the hydroxy group) were identified as the
only impurities. We also tried the reaction using only DMF to
Scheme 2. Biocatalyzed heterogeneous oxidation of prochiral 2-methyl-1,3-
propandiol (1) and in-line purification of the product through a catch-and-
release protocol.
Scheme 3. The chlorination reaction using a 10 mL reactor coil. BPR: 200 psi.
Solvent, temperature and residence time were optimized as summarized in
Table 1.
Table 1. Conditions tested for the chlorination reaction.[a]
Entry T [8C] tr [min] Yield 3
[b] [%]
1[c] 85 60 80
2[c] 100 60 100
3[c] 110 30 100
4[c] 125 15 70
5[c] 150 15 70
6[d] 100 30 100
7[d] 100 15 85
[a] See the Experimental Section for the reaction conditions. [b] Conver-
sions were determined by 1H NMR, after evaporation of the solvent.
[c] Flow stream A: 2 (1m) in toluene/DMF (9:1) containing 0.1 equiv imi-
dazole; flow stream B: SOCl2 in toluene (3m). [d] Flow stream A: 2 in DMF
containing 1% imidazole; flow stream B: neat SOCl2.
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prepare the solution of 2 (Table 1, entries 6 and 7) and ob-
served complete conversion at 100 8C in 30 min.
Intermediate 3 was then submitted to amide coupling with
l-proline (Scheme 4). Because the final goal was to have all the
synthetic steps in-line, without a break in the workflow, we de-
cided to use for this reaction the same solvent as in the previ-
ous step.
Thus, 3 was dissolved in toluene (1m solution), mixed with
an aqueous basic (NaOH, 3 equiv) solution of l-proline (2m so-
lution, 2 equiv) and flowed into a 2 mL perfluoroalkoxy alkane
(PFA) reactor coil. The reaction was performed at room temper-
ature, without cooling, and was rapid, giving full conversion
within only 1 min of residence time. In-line acidification to
pH 2 followed by a liquid–liquid separation using a Zaiput sep-
arator were performed, affording the desired product 4.
The final step was the nucleophilic substitution of the chlor-
ine with the thiol group (Scheme 5). Again, we used toluene as
an organic solvent and the reaction was studied in a biphasic
system toluene/degassed water, used to reduce the possible
formation of oxidized byproducts.
To perform the substitution, an excess of NaSH (3 equiv) was
efficiently used. An in-line acidification followed by a liquid–
liquid separation allowed captopril to be obtained from the or-
ganic phase that was evaporated and analyzed by 1H NMR
spectroscopy. Temperature and residence time were optimized
and the results are summarized in Table 2. The reaction was
complete in 30 min at 125 8C (Table 2, entry 4).
Once the reactions were separately optimized, we next de-
veloped a continuous multistep production of captopril that
would be sufficiently robust for multiple hours of continuous
work (Scheme 6). We assembled the system such that the
product stream from the chlorination reaction, obtained using
the conditions reported in Table 1 (entry 3), was immediately
submitted to the coupling reaction in a toluene/water biphasic
system, as described above. To this end, first we evaluated the
amount of NaOH necessary to neutralize the excess acid from
the chlorination step. The T-junction was cooled to 0 8C for the
neutralization and, in this way, the uncontrolled exothermic
neutralization and the release of large quantities of HCl vapors
were avoided. In this set-up, the residence time for the cou-
pling reaction in the 2 mL reactor coil was approximately
3 min (Scheme 6). After separation of the two phases, the exit-
ing organic solution of compound 4 was collected in a vial,
acting as a reservoir, and then directly used for the substitution
reaction. The solution was pumped into a 10 mL reactor coil
after mixing with the solution of NaSH in degassed water and
heated at 125 8C.
After in-line acidification, extraction and evaporation of the
solvent, the resulting crude material was purified by column
chromatography to yield pure captopril as a white solid. The
1H NMR spectrum and the optical rotation matched those re-
ported in the literature.[18]
Scheme 4. The coupling reaction using a 2 mL reactor coil. Pressure: 200 psi.
Scheme 5. The nucleophilic substitution using a 10 mL reactor coil. Pressure:
200 psi.
Table 2. Conditions tested for the nucleophilic substitution.[a]
Entry T [8C] tr [min] Yield 5
[b] [%]
1 50 60 70
2 80 60 90
3 100 60 93
4 125 30 100
5 125 15 75
[a] See the Experimental Section for the reaction conditions. [b] Conver-
sions were determined by 1H NMR spectroscopy after evaporation of the
solvent.
Scheme 6. Three-step flow chemical synthesis of captopril. BPR: 200 psi.
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3. Conclusions
The multistep flow synthesis presented here enabled captopril
to be obtained in an overall yield of 50% after crystallization.
Biocatalytic oxidation facilitated the conversion of a prochiral
substrate into a chiral intermediate with high enantiomeric
excess. Three chemical transformations were performed with-
out isolation of the intermediates. The separation of co-prod-
ucts, by-products, and excess reagents was achieved in-line.
These results clearly highlight the benefits of performing multi-
step chemical synthesis in a flow environment. As a further ad-
vantage, our synthetic protocol benefits from the use of an en-
vironmentally friendly biocatalytic oxidation, avoiding the use
of toxic chemical oxidants. The bioprocess might be further
linked to the chemical transformations by optimizing the ex-
traction of acid (2) with organic solvents, for example, using
specific organic-acid-complexing carriers.[19] In light of a future
scale-up, whereas none of the chemical steps have foreseen
limitations, further efforts should be directed toward increasing
the productivity of the first biocatalyzed step, which at present
represents a bottleneck in the process. The new proposed pro-
tocol for the synthesis of captopril represents a powerful inte-
gration of biocatalysis and flow-chemistry technology.
Experimental Section
All reagents and solvents were purchased from Sigma–Aldrich. The
continuous flow reactions were performed using a commercial
R2C/R4 flow reactor (Vapourtec, Bury St. Edmunds, Suffolk, UK)
equipped with Omnifit glass columns (15 mm i.d. V 100 mm
length) and PFA reactor coils (2 and 10 mL, respectively). The R2C
unit is the pumping unit that contains two adapted Knauer
pumps, which are able to pump highly concentrated and corrosive
acids. R4 is the heating unit with four heating positions. The addi-
tional HPLC pumps necessary to perform the overall synthesis
were provided by another R2+ /R4 flow reactor (Vapourtec) and
by two external pumps (ThalesNano). The temperature sensor sits
on the wall of the PFA tubing. The pressure was controlled by
using two 100 psi BPRs. In-line liquid–liquid extractions were per-
formed using a Zaiput separator. 1H NMR and 13C NMR spectra
were recorded with a Varian Mercury 300 (300 MHz) spectrometer.
Chemical shifts (d) are expressed in ppm, and coupling constants
(J) are expressed in Hz. The molar conversion of the biotransforma-
tion was determined by HPLC analysis using a Luna NH2 100 a
column (250 mmV4.6 mm, particle size 5 mm, Phenomenex,
Aschaffenburg, Germany) and a Biorad refractor index detector
with an acidic aqueous KH2PO4 buffer (20 mm, pH 2.7) as the
mobile phase (flow rate 0.2 mLmin@1). The samples (40 mL) were in-
jected as soon as collected and without further treatment. The
enantiomeric composition of 2 was determined by gas chromato-
graphic analysis of the corresponding methyl ester [methyl (R)-3-
hydroxy-2-methylpropionate: tr=3.6 min], obtained after treat-
ment with diazomethane, using a chiral capillary column (diameter
0.25 mm, length 25 m, DMePeBeta-CDX-PS086, MEGA, Legnano,
Italy). Optical rotation determinations were performed using
a Jasco P-1010 spectropolarimeter coupled with a Haake N3-B ther-
mostat. MS analyses were performed on a Varian 320-MS triple
quadrupole mass spectrometer with an electrospray ionization
(ESI) source. Microanalyses (C, H, N) were within :0.4% of theoret-
ical values.
Strain Preparation
The A. aceti MIM 2000/28 strain was routinely maintained on GYC
agar plates [glucose (50 gL@1), yeast extract (10 gL@1), CaCO3
(30 gL@1), agar (15 gL@1), pH 6.3] at 28 8C. Strain was inoculated
into 100 mL Erlenmeyer baffled flask containing GLY medium
[yeast extract (10 gL@1) and glycerol (25 gL@1), pH 5; 20 mL]. After
growth for 24 h (shaking at 150 rpm, 28 8C), the liquid culture was
entirely used to inoculate a 1 L Erlenmeyer baffled flask containing
GLY medium (150 mL). Flasks were grown for 24 h at 28 8C, with
shaking at 150 rpm.
Preparation of Dry Alginate Beads
Gel beads were prepared by ionotropic gelation, by following
a protocol previously developed by us:[17] a 4% (w/v) sodium algi-
nate solution was prepared in distilled water and stirred until a ho-
mogeneous clear solution was formed. The solution was allowed
to settle for 2 h in order to eliminate the air bubbles. The alginate
solution was then gently mixed in a 1:1 (w/w) ratio with a suspen-
sion of A. aceti cells (40 ODmL@1) in sodium acetate buffer (20 mm,
pH 6). The resulting mixture was then pumped dropwise into
a slightly agitated CaCl2 solution (0.2m). Calcium alginate beads
were agitated for 20 min, then filtered, washed with deionized
water and dried at 25 8C for 16 h.
Synthesis of (R)-3-Hydroxy-2-methylpropanoic Acid (2)
Dry alginate beads (400 mg) were packed into a glass column (i.d.
15 mm) and swelled until their volume tripled by flowing acetate
buffer (20 mm, pH 6) through the column (flow rate: 400 mLmin@1,
60 min). The final volume of the bed was 5.1 mL. Air was delivered
at 17 psi; its flow was measured using the method described in
Ref. [20]. To ensure a constant flow, a BRP (40 psi) was applied
before the air tank. An aqueous solution of 1 (1 gL@1, 40 mL) was
pumped at 60 mLmin@1, joining the airflow at the T-junction,
before entering the column in which the oxidation occurs in ap-
proximately 10 min. The exiting flow stream was directed into a de-
compression column. A BPR (5 psi) ensured a constant and con-
trolled flow of aqueous phase leaving the column. The aqueous
stream was directed into a column filled with Ambersep 900 OH
resin (2 g) and, after washing the column with water (20 mL,
0.5 mLmin@1), the trapped acid was released by flowing HCl (1n,
5 mL). After lyophilization, compound 2 was isolated as pale yellow
oil (42 mg).
To obtain a larger amount of 2, 1.6 g of alginate beads were used,
with a reactor volume of 20 mL. At this scale, 170 mg of com-
pound 2 was isolated (91% yield). [a]20D =@11.55 (c=1.00 in EtOH);
1H NMR (300 MHz, CDCl3): d = 1.22 (d, J=7.4 Hz, 3H), 2.10 (s, 1H),
2.68–2.80 (m, 1H), 3.75 (d, J=6.0 Hz, 2H), 5.70 ppm (brs, 1H);
13C NMR (75 MHz, CDCl3): d = 13.2, 41.6, 64.0, 180.1 ppm; MS (ESI):
m/z : 102.9 [M–H]@ ;[21] HPLC analysis: 1, tr=22 min; 2, tr=18 min.
Synthesis of (R)-3-Chloro-2-methylpropanoyl Chloride (3)
A solution of 2 (52 mg, 0.5 mmol) was prepared in anhydrous tolu-
ene (410 mL). Imidazole (3.5 mg, 0.1 equiv) and DMF (50 mL) were
added to the solution. A second solution of thionyl chloride
(125 mL, 3.5 equiv) was prepared in anhydrous toluene (375 mL).
The two solutions were mixed into a T-piece and flowed through
a 10 mL reactor coil according to the conditions reported in
Table 1. A 200 psi backpressure regulator was applied to the
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system. The exiting solution was collected, the solvent was evapo-
rated under reduced pressure to yield 3 as a crude oil, which was
analyzed by 1H NMR spectroscopy. 1H NMR (300 MHz, CDCl3): d=
1.42 (d, 3H), 3.20–3.31 (m, 1H), 3.66–3.80 ppm (m, 2H).
Synthesis of (S)-1-[(S)-3-Chloro-2-methylpropanoyl]pyrroli-
dine-2-carboxylic Acid (4)
A solution of compound 3 (70 mg, 0.5 mmol) in toluene (0.5 mL)
was prepared. A second solution of l-proline (115 mg, 2 equiv) and
NaOH (60 mg, 3 equiv) was prepared in water (0.5 mL). The two
solutions were flowed at a total rate of 2 mLmin@1 through a 2 mL
reactor coil, that had been washed with a mixture of toluene and
water, at room temperature. The aqueous phase was acidified to
pH 2 by introducing a flow of HCl (6n, 1 mLmin@1) and the result-
ing biphasic system was mixed using a T-junction into an EtOAc
stream (1 mLmin@1) to perform in-line extraction. The two phases
were separated in-line using a Zaiput liquid–liquid separator. A
200 psi backpressure was applied to the system. The organic sol-
vent was dried over anhydrous Na2SO4 and evaporated under re-
duced pressure to yield 4 as a crude solid, which was analyzed by
1H NMR spectroscopy. [a]20D =@103.6 (c=1 in EtOH); 1H NMR
(300 MHz, CDCl3): d=1.24 (d, 3H, J=7.0), 2.02–2.18 (m, 4H), 2.96–
3.08 (m, 1H), 3.44–3.51 (m, 1H), 3.57–3.72 (m, 2H), 3.81 (t, 1H, J=
10.4), 4.62–4.69 (m, 1H), 11.30 (br s, 1H); 13C NMR (75 MHz, CDCl3):
d=15.8, 24.9, 27.7, 41.3, 45.8, 47.7, 59.6, 173, 175 ppm; MS (ESI):
m/z : 217.9 [M–H]@ ; elemental analysis calcd (%) for C9H14ClNO3 : C
49.21, H 6.42, N 6.38; found: C 49.00, H 6.31, N 6.50.
Synthesis of (S)-1-[(S)-3-Chloro-2-methylpropanoyl]pyrroli-
dine-2-carboxylic Acid (Captopril, 5)
A solution of compound 4 (22 mg, 0.1 mmol) in toluene (0.1 mL)
was prepared. A second solution of NaSH (21 mg, 3 equiv) was pre-
pared using degassed water (0.1 mL). The two solutions were
flowed through a 10 mL reactor coil. A 200 psi backpressure was
applied to the system. Reaction time and temperature were opti-
mized, as reported in Table 2. The aqueous phase was acidified at
pH 2 by introducing a flow of HCl (2n) and the resulting biphasic
system was mixed using a T-junction into an EtOAc stream to per-
form in-line extraction. The two phases were separated in-line
using a Zaiput liquid–liquid separator. The organic solvent was
dried over anhydrous Na2SO4 and evaporated under reduced pres-
sure to yield 5 as a pale yellow crude solid, which was analyzed by
1H NMR spectroscopy. [a]20D =@128.5 (c=1 in EtOH); lit=@129.4
(c=1.35 in EtOH at 22 8C);[18] 1H NMR (300 MHz, CDCl3): d=1.24 (d,
J=7.0 Hz, 3H), 1.58 (t, J=9.2 Hz, 1H), 2.02–2.18 (m, 4H), 2.43–2.51
(m, 1H), 2.79–2.90 (m, 2H), 3.55–3.71 (m, 2H), 4.62–4.69 (m, 1H),
11.30 ppm (br s, 1H); 13C NMR (75 MHz, CDCl3): d=17.0, 20.8, 24.7,
27.4, 42.5, 47.4, 59.2, 173.0, 175.0 ppm; MS (ESI): m/z : 215.9 [M–
H]@ ; elemental analysis calcd (%) for C9H15NO3S: C 49.75, H 6.96, N
6.45; found: C 49.60, H 6.89, N 6.52.
Three-Step Continuous-Flow Synthesis of Captopril (5)
A solution of 2 (156 mg, 1.5 mmol) in anhydrous toluene (1.23 mL)
was prepared. Imidazole (10.5 mg, 0.1 equiv) and DMF (150 mL)
were added to the solution. A second solution of thionyl chloride
(375 mL, 3.5 equiv) was prepared using anhydrous toluene
(1.12 mL). The two solutions were flowed through a 10 mL coil re-
actor that was maintained at 110 8C, with a residence time of
30 min (total flow rate 0.33 mLmin@1). Then, the exiting flow was
merged at a T-junction with an aqueous solution (1.5 mL) of l-pro-
line (2 equiv) and NaOH (7 equiv). This then entered a 2 mL reactor
coil, maintained at room temperature with a residence time of
3 min (total flow rate 0.66 mLmin@1). The aqueous phase was acidi-
fied to pH 2 by adding a flow stream of HCl (6n, 0.33 mLmin@1)
and the resulting biphasic system was mixed using a T-junction
into an EtOAc stream (0.33 mLmin@1) to perform an in-line extrac-
tion. The two phases were separated in-line using a Zaiput liquid–
liquid separator. The organic phase was collected in a vial acting as
a substrate reservoir for the final nucleophilic substitution reaction.
The organic phase was pumped and mixed with a solution of
NaSH (c=1.5m, 3 equiv) in degassed water, and entered a 10 mL
coil reactor maintained at 125 8C for 30 min (total flow rate
0.66 mLmin@1). A 200 psi backpressure was added to the whole
system. The exiting flow was then acidified to pH 1 with HCl (2n)
and a continuous extraction with the Zaiput liquid–liquid separator
was performed. The organic solvent was dried over anhydrous
Na2SO4 and evaporated under reduced pressure to yield a crude
material that was purified by column chromatography (dichloro-
methane/methanol 98:2) to yield captopril, which was crystallized
from ethyl acetate/hexane (1:1, total volume 1 mL; 160 mg, 50%).
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